TP53 mutations among molecular subtypes of HER2-positive tumors

被引：0
|
作者：
Å Helland
M Nicolau
Y Ji
A Langerød
DE Sommervoll
A Bergamaschi
JR Pollack
A-L Børresen-Dale
SS Jeffrey
机构：
[1] The Norwegian Radium Hospital,Department of Oncology
[2] The Norwegian Radium Hospital,Department of Genetics
[3] Stanford University School of Medicine,Department of Surgery
[4] Statistics Norway,Department of Research
[5] Stanford University School of Medicine,Department of Pathology
来源：
Breast Cancer Research | / 7卷
关键词：
Breast Carcinoma; Molecular Subtype; TP53 Mutation; Ductal Breast Carcinoma; Expression Threshold;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] TP53 mutations among molecular subtypes of HER2-positive tumors
    Helland, Å
    Nicolau, M
    Ji, Y
    Langerod, A
    Sommervoll, DE
    Bergamaschi, A
    Pollack, JR
    Borresen-Dale, AL
    Jeffrey, SS
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S53 - S53
  • [2] Increased Rate of HER2-Positive Breast Cancers among Women with Germline TP53 Mutations
    Melhem-Bertrandt, A.
    Ready, K. J.
    Gutierrez-Barrera, A. M.
    Litton, J.
    Strong, L. C.
    Olopade, O. I.
    Hortobagyi, G. N.
    Arun, B. K.
    CANCER RESEARCH, 2010, 70
  • [3] Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer
    Kotoula, V.
    Zagouri, F.
    Alexopoulou, Z.
    Gogas, H.
    Lakis, S.
    Pentheroudakis, G.
    Bobos, M.
    Papadopoulou, K.
    Tsolaki, E.
    Skondra, M.
    Karavasilis, V.
    Koutras, A.
    Chrisafi, S.
    Christodoulou, C.
    Papakostas, P.
    Linardou, H.
    Markopoulos, C.
    Zografos, G.
    Samantas, E.
    Fountzilas, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S270 - S270
  • [4] Early onset HER2-positive breast cancer is associated with germline TP53 mutations
    Melhem-Bertrandt, Amal
    Bojadzieva, Jasmina
    Ready, Kaylene J.
    Obeid, Elias
    Liu, Diane D.
    Gutierrez-Barrera, Angelica M.
    Litton, Jennifer K.
    Olopade, Olufunmilayo I.
    Hortobagyi, Gabriel N.
    Strong, Louise C.
    Arun, Banu K.
    CANCER, 2012, 118 (04) : 908 - 913
  • [5] A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
    Wilson, J. R. F.
    Bateman, A. C.
    Hanson, H.
    An, Q.
    Evans, G.
    Rahman, N.
    Jones, J. L.
    Eccles, D. M.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 (11) : 771 - 774
  • [6] Prevalence of Germline TP53 Mutations in Young Women with HER2-Positive Breast Cancer.
    Dick, M. G.
    Masciari, S.
    Miron, A.
    Miron, P.
    Foley, K.
    Gelman, R.
    Dillon, D. A.
    Richardson, A. L.
    Verselis, S. J.
    Lypas, G.
    Krop, I. E.
    Garber, J. E.
    CANCER RESEARCH, 2011, 71
  • [7] TP53 Mutations in Canine Brain Tumors
    York, D.
    Higgins, R. J.
    LeCouteur, R. A.
    Wolfe, A. N.
    Grahn, R.
    Olby, N.
    Campbell, M.
    Dickinson, P. J.
    VETERINARY PATHOLOGY, 2012, 49 (05) : 796 - 801
  • [8] Early onset HER2-positive breast cancer is associated with germline TP53 mutations (vol 118, pg 908, 2012)
    Melhem-Bertrandt, A.
    Bojadzieva, J.
    Ready, K. J.
    Obeid, E.
    Liu, D. D.
    Gutierrez-Barrera, A. M.
    Litton, J. K.
    Olopade, O., I
    Hortobagyi, G. N.
    Strong, L. C.
    Arun, B. K.
    CANCER, 2012, 118 (09) : 2561 - 2561
  • [9] The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer
    Carla Escudeiro
    Carla Pinto
    Joana Vieira
    Ana Peixoto
    Pedro Pinto
    Manuela Pinheiro
    Catarina Santos
    Joana Guerra
    Susana Lisboa
    Rui Santos
    João Silva
    Conceição Leal
    Nuno Coimbra
    Paula Lopes
    Marco Ferreira
    Ana B. Sousa
    Manuel R. Teixeira
    Familial Cancer, 2021, 20 : 173 - 180
  • [10] Molecular profiling identifies distinct subtypes across TP53 mutant tumors
    Chen, Xin
    Liu, Tianqi
    Wu, Jianqi
    Zhu, Chen
    Guan, Gefei
    Zou, Cunyi
    Guo, Qing
    Ren, Xiaolin
    Li, Chen
    Cheng, Peng
    Cheng, Wen
    Wu, Anhua
    JCI INSIGHT, 2022, 7 (23)
12345